Sanofi India

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE058A01010
  • NSEID: SANOFI
  • BSEID: 500674
INR
3,326.20
-19.3 (-0.58%)
BSENSE

Aug 10

BSE+NSE Vol: 11.53 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Akums Drugs
Supriya Lifesci.
Senores Pharma.
P & G Health Ltd
Aarti Pharma
SPARC
Sanofi India
Strides Pharma
FDC
Sanofi Consumer
Orchid Pharma
Why is Sanofi India Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of -9.00% and Operating profit at -7.95% over the last 5 years
2
Flat results in Mar 26
  • NO KEY NEGATIVE TRIGGERS
3
Stock is technically in a Mildly Bearish range
  • The technical trend has deteriorated from Mildly Bearish on 06-May-26 and has generated -6% returns since then
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -49.13% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Sanofi India should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Sanofi India for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Sanofi India
-36.1%
-2.48
19.80%
Sensex
-1.65%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-9.18%
EBIT Growth (5y)
-8.96%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
2.25
Tax Ratio
25.65%
Dividend Payout Ratio
86.59%
Pledged Shares
0
Institutional Holding
25.56%
ROCE (avg)
118.75%
ROE (avg)
50.57%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
20
Industry P/E
37
Price to Book Value
9.27
EV to EBIT
16.38
EV to EBITDA
15.14
EV to Capital Employed
15.48
EV to Sales
4.05
PEG Ratio
NA
Dividend Yield
3.70%
ROCE (Latest)
94.51%
ROE (Latest)
41.66%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...